Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: J Immunol Methods. 2017 May 3;448:1–8. doi: 10.1016/j.jim.2017.04.012

Table 3.

Performance of EHMIL serum HEV IgM and HEV IgA and saliva HEV IgA assays.

HEV immunoassay Samples Cut-off Positive Negative Sensitivity Specificity
Wantai HEV IgM 136a 0.26 OD 19/19 117/117 Reference Reference

EHMIL serumb HEV IgM
 (1) No adjustment 136 2857 MFI 18/19 115/117 94.7% 98.3%
 (2) Ratio 136 4.3 18/19 115/117 94.7% 98.3%
 (3) Difference 136 1437 MFI 18/19 115/117 94.7% 98.3%

EHMIL serumb HEV IgA
 (1) No adjustment 136 641 MFI 18/19 116/117 94.7% 99.1%
 (2) Ratio 136 11.4 19/19 115/117 100.0% 98.3%
 (3) Difference 136 543 MFI 19/19 116/117 100.0% 99.1%

EHMIL salivac HEV IgA
 (1) No adjustment 134d 571 MFI 7/19 113/115 36.8% 98.3%
 (2) Ratio 134d 2.3 17/19 113/115 89.5% 98.3%
 (3) Difference 134d 238 MFI 13/19 114/115 68.4% 99.1%
a

Five serum samples were classified as “borderline” (neither positive nor negative) by Wantai HEV IgM assay and were therefore excluded from the sensitivity and specificity analysis.

b

Serum samples were diluted 1:1000 for EHMIL assay;

c

saliva samples were diluted 1:8 for EHMIL assay;

d

two saliva samples were missing.

OD=optical density; MFI=Median fluorescence intensity.

Note: HEV antigen used in EHMIL assays is fused with GST tag. Cut-off value to calculate sensitivity and specificity of EHMIL HEV assays determined using (1) only HEV specific signal, (2) ratio of HEV to GST specific signal, (3) difference between HEV and GST specific signal.